Handelsman Y - Search Results

1

Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.

Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR, Nagendran S. Rosenstock J, et al. Among authors: handelsman y. Postgrad Med. 2012 Jul;124(4):7-13. doi: 10.3810/pgm.2012.07.2560. Postgrad Med. 2012. PMID: 22913889 Clinical Trial.

2

The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.

Handelsman Y. Handelsman Y. Postgrad Med. 2009 May;121(3 Suppl 1):5-6. doi: 10.3810/pgm.2009.05.suppl53.286. Postgrad Med. 2009. PMID: 19494471 No abstract available.

3

The role of colesevelam HCl in type 2 diabetes mellitus therapy.

Handelsman Y. Handelsman Y. Postgrad Med. 2009 May;121(3 Suppl 1):19-24. doi: 10.3810/pgm.2009.05.suppl53.289. Postgrad Med. 2009. PMID: 19494474 Review.

4

Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.

Rigby SP, Handelsman Y, Lai YL, Abby SL, Tao B, Jones MR. Rigby SP, et al. Among authors: handelsman y. Endocr Pract. 2010 Jan-Feb;16(1):53-63. doi: 10.4158/EP09146.OR. Endocr Pract. 2010. PMID: 19789153 Clinical Trial.

5

Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.

Handelsman Y, Abby SL, Jin X, Donovan JM, Jones MR. Handelsman Y, et al. Postgrad Med. 2009 Nov;121(6):62-9. doi: 10.3810/pgm.2009.11.2078. Postgrad Med. 2009. PMID: 19940418

6

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.

Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR. Rosenstock J, et al. Among authors: handelsman y. Endocr Pract. 2010 Jul-Aug;16(4):629-40. doi: 10.4158/EP10130.OR. Endocr Pract. 2010. PMID: 20634175 Clinical Trial.

7

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.

Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL. Handelsman Y, et al. Endocr Pract. 2010 Jul-Aug;16(4):617-28. doi: 10.4158/EP10129.OR. Endocr Pract. 2010. PMID: 20634176 Clinical Trial.

8

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial.

Ratner RE, Rosenstock J, Boka G; DRI6012 Study Investigators. Ratner RE, et al. Diabet Med. 2010 Sep;27(9):1024-32. doi: 10.1111/j.1464-5491.2010.03020.x. Diabet Med. 2010. PMID: 20722676 Free PMC article. Clinical Trial.

9

Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?

Handelsman Y, Fonseca V, Rosenstock J. Handelsman Y, et al. Expert Rev Clin Pharmacol. 2012 Jan;5(1):43-54. doi: 10.1586/ecp.11.73. Expert Rev Clin Pharmacol. 2012. PMID: 22142158 Review.

10

Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.

Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR. Rosenstock J, et al. Among authors: handelsman y. Postgrad Med. 2012 Jul;124(4):14-20. doi: 10.3810/pgm.2012.07.2564. Postgrad Med. 2012. PMID: 22913890 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters